Longevity Health (NASDAQ:XAGE) Stock Price Down 5.3% – Here’s What Happened

Longevity Health Holdings, Inc. (NASDAQ:XAGE)’s share price dropped 5.3% during trading on Friday . The company traded as low as $0.4301 and last traded at $0.4301. Approximately 493 shares were traded during trading, a decline of 100% from the average daily volume of 686,172 shares. The stock had previously closed at $0.4540.

Longevity Health Stock Down 5.3%

The stock has a market capitalization of $766,438.20, a PE ratio of -0.11 and a beta of 0.34. The company has a 50 day moving average of $0.51.

Institutional Investors Weigh In On Longevity Health

An institutional investor recently bought a new position in Longevity Health stock. Bank of Montreal Can purchased a new position in Longevity Health Holdings, Inc. (NASDAQ:XAGE) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,000 shares of the company’s stock, valued at approximately $30,000. Bank of Montreal Can owned approximately 1.20% of Longevity Health at the end of the most recent quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Longevity Health Company Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.